Clinical Trial

Tranexamic Acid Dose and Remifentanil Titration in Septorhinoplasty

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2026 (before its estimated August 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective observational cohort study aims to investigate whether the weight-based equivalent (mg/kg) of a fixed 1 g dose of tranexamic acid administered during septorhinoplasty is associated with intraoperative remifentanil titration frequency and perceived anesthesiologist workload. Although tranexamic acid is routinely given as a fixed dose, its mg/kg equivalent varies according to patient weight and may influence hemodynamic management during controlled hypotension. The primary outcome is the total number of remifentanil infusion rate adjustments during surgery. Secondary outcomes include total remifentanil consumption and postoperative anesthesiologist workload assessed using the NASA Task Load Index (NASA-TLX).
Trial Details
NCT Number NCT07450794
Lead Sponsor Istinye University
Conditions Anesthesiologist Workload
Enrollment 90 participants
Start Date 2026-03-05
Primary Completion 2026-08-05 (estimated)
Study Completion 2026-08-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-05